Summary
- Current Price
- As of today, DMRA price is $32.99, up +4.80% on
- Current Price All-Time High
- DMRA price is currently -92.66% below its historical high of $449.75 set on
- Market Cap
- DMRA current market cap is $2B, up +42543.15% over the past 365 days
- Revenue
- DMRA current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for DMRA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Damora Therapeutics, Inc. |
| Ticker | NASDAQ: DMRA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | galecto.com |
| Employees | 5 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $32.99 | |
| Price, 1D Change | +4.80% | |
| $2B | ||
| - | ||
| - | ||
| 2.05 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$152.99 | ||
| EPS, 1Y Change | -725.75% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | GLTO | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$152.99 | ||
| EPS Estimate | N/A | -$1.76 |
| EPS Est. Change | N/A | +98.85% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $32.99 | |
| Price Target | - | $45.00 |
| Price Tgt. Change | - | +36.40% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$18.53 | - | |
| -$0.96 | -$152.99 | -15,908.13% | |
| -$1.76 | N/A | +98.85% | |
| -$2.08 | N/A | +98.64% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $32.99 | |
| $22.85 | ||
| $24.99 | ||
| $21.87 | ||
| $26.21 | ||
| $2.15 | ||
| 2.05 | ||
| $2.57 | ||
| 66.60 | ||
| 106.98% | ||
| 476.25% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$152.99 | ||
| -$34.00K | ||
| - | ||
| -$36.56M | ||
| - | ||
| -$209.84M | ||
| - | ||
| -$36.53M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 12.98 | ||
| 12.98 | ||
| - | ||
| - | ||
| 54.73 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 5.36 | ||
| -23.18 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$175.87M | ||
| $257.62M | ||
| $260.53M | ||
| $260.42M | ||
| $21.49M | ||
| $20.07M | ||
| $1.41M | ||
| $15.00K | ||
| $444.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $209.84M | ||
| $36.53M | ||
| $34.00K | ||
| $9.69M | ||
| $34.00K | ||
| $0.00 | ||
| $50.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$6.73M | ||
| -$17.37M | ||
| $266.84M | ||
| $0.00 | ||
| -$6.73M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wedbush | → | |
| HC Wainwright & Co. | ||
| Wedbush | ||
| RBC Capital | ||
| Evercore ISI Group | ||
| UBS | ||
| Guggenheim | → | |
| Leerink Partners | ||
| Guggenheim | → | |
| Guggenheim |
Analyst sentiment
Institutional ownership
Screeners with DMRA
FAQ
What is the ticker symbol for Damora Therapeutics, Inc.?
The ticker symbol for Damora Therapeutics, Inc. is NASDAQ:DMRA
Does Damora Therapeutics, Inc. pay dividends?
No, Damora Therapeutics, Inc. does not pay dividends
What sector is Damora Therapeutics, Inc. in?
Damora Therapeutics, Inc. is in the Healthcare sector
What industry is Damora Therapeutics, Inc. in?
Damora Therapeutics, Inc. is in the Biotechnology industry
What country is Damora Therapeutics, Inc. based in?
Damora Therapeutics, Inc. is headquartered in United States
When did Damora Therapeutics, Inc. go public?
Damora Therapeutics, Inc. initial public offering (IPO) was on October 29, 2020
Is Damora Therapeutics, Inc. in the S&P 500?
No, Damora Therapeutics, Inc. is not included in the S&P 500 index
Is Damora Therapeutics, Inc. in the NASDAQ 100?
No, Damora Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Damora Therapeutics, Inc. in the Dow Jones?
No, Damora Therapeutics, Inc. is not included in the Dow Jones index
When was Damora Therapeutics, Inc. last earnings report?
Damora Therapeutics, Inc.'s most recent earnings report was on August 11, 2025
When does Damora Therapeutics, Inc. report earnings?
The next expected earnings date for Damora Therapeutics, Inc. is August 11, 2026
Data Sources & References
- DMRA Official Website galecto.com
- DMRA Profile on Yahoo Finance finance.yahoo.com/quote/DMRA
- DMRA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dmra